P PRIMESTOCKFINDER.COM

MVP Shares Medical Developments International Limited

ASX · ASX
$0.37 +1.92% Prices as of close 2026-10-27

Last in our picks 2026-10-19 — not in the current list; analysis below is from that screen

Respiratory and emergency-care products offer recurring commercial growth with improving operating leverage.

Future value: $0.45 (+12.50%) · 6-12 months

Signal breakdown

  • ▸Commercial momentum and healthcare-demand tailwinds.
  • ▾Below 50-day MA (-13.29%)
  • ▾Near 52-week low (9.1% of range)

Is MVP a buy right now?

Trend: MVP is trading below the 50-day average (-17.33%), RSI 38 — neutral momentum, with a 3-month return of -15.45%.

Valuation & quality: Medical Developments International Limited trades on a trailing P/E of 37.2, forward P/E 9.9, price-to-book 0.75; fundamentals show net margin 1.5%, return on equity 1.1%, revenue growth 10.1% year on year.

Analyst consensus: 2 analysts have a mean 12-month price target of A$2.30 (+518.3% vs the last close; range A$1.00 – A$3.60), consensus rating “strong buy”.

Our screen: ACCUMULATE (score 1) — Respiratory and emergency-care products offer recurring commercial growth with improving operating leverage.

Computed from end-of-day data; not personal advice.

12-month price chart

0.54 0.37 FebMarAprMayJunJulAugSepOct
Daily close, 2026-02-08 → 2026-10-27 (AUD). Range 0.37 – 0.54.

Monthly returns

Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
-11.40%+12.80%-13.60%+5.30%+15.00%+0.00%-4.30%-15.90%

Fundamentals

Market cap
$41.9M
P/E (ttm)
37.2
Forward P/E
9.9
EPS (ttm)
$0.01
Price / book
0.75
Beta
1.56
Net margin
1.5%
ROE
1.1%
Revenue growth
10.1%
Revenue (ttm)
$42.6M
Free cash flow
$5.9M
Debt / equity
3%
52-wk range
$0.37 – $0.73
Volume
21,961
Avg volume (3m)
182,357

Analyst price target

Mean target
$2.30
Low
$1.00
High
$3.60
Analysts
2
Consensus
STRONG BUY

Technical signals

RSI (14)
37.7
vs 50-day MA
-17.33%
1-mo return
-15.45%
3-mo return
-15.45%
Volume z-score
1.26

About Medical Developments International Limited

Medical Developments International Limited provides emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments.

Sector: Healthcare · Industry: Drug Manufacturers - Specialty & Generic · Australia · Website

Related Biotech picks

CSL.AXCSL LimitedMSB.AXMesoblast LimitedIMR.AXImricor Medical SystemSLD.AXSaluda Medical, Inc.NUZ.AXNeurizon Therapeutics NEU.AXNeuren PharmaceuticalsDXB.AXDimerix LimitedNYR.AXNyrada Inc.

Browse: all ASX stocks · Biotech picks · today's movers

General information only (Australia). This is general information, not financial product advice. It doesn't consider your objectives, financial situation or needs — consider its appropriateness and seek licensed advice before acting. Not a recommendation to buy or sell any financial product.

Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.